Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Arrowhead Research Corporation Retains The Piacente Group, Inc. as Strategic Investor Relations Consulting Firm

Abstract:
Arrowhead Research Corporation (NASDAQ: ARWR) ("Arrowhead"), a leading nanotechnology company, who, through its majority-owned subsidiaries, commercializes new technologies in the areas of life sciences, electronics and energy, today announced that it has retained The Piacente Group, Inc. ("TPG"), a full service investor relations consulting firm based in New York City. TPG will assist Arrowhead in implementing investor communications and Wall Street outreach programs aimed at making new connections in the financial community to the Company.

Arrowhead Research Corporation Retains The Piacente Group, Inc. as Strategic Investor Relations Consulting Firm

PASADENA, CA | Posted on November 18th, 2008

"The Piacente Group has a great track record of bringing growth companies like Arrowhead and interested Wall Street investors together," said Christopher Anzalone, President and Chief Executive Officer of Arrowhead. "As we build value for Arrowhead shareholders by way of introducing new products to market via our subsidiaries in the healthcare, electronics and clean energy industries, we look to The Piacente Group to communicate our business strategy and growth initiatives to the right investment audience."

Brandi Piacente, President of TPG, stated: "We are excited to work with Arrowhead, a leading innovator in the commercialization of nanotechnology-enabled products, as we believe they have a compelling investment story and the qualifications to take a distinctive and leading position in a growing industry. We look forward to partnering with management to implement a strategic and targeted investor relations program that will assist in further enhancing value for shareholders."

####

About Arrowhead Research Corporation
Arrowhead Research Corporation (www.arrowheadresearch.com) (NASDAQ:ARWR) is a publicly-traded nanotechnology company commercializing new technologies in the areas of life sciences, electronics, and energy. Arrowhead is building value for shareholders through the progress of majority owned subsidiaries. Currently, Arrowhead has four subsidiaries commercializing nanotech products and applications and investments in two minority-owned subsidiaries.

About The Piacente Group, Inc.

The Piacente Group, Inc. is a full service investor relations and financial communications consulting firm based in New York City with offices in San Francisco and Beijing. The Piacente Group develops and implements strategic programs aimed at broadening investment community sponsorship through best practice execution. The Piacente Group is dedicated to providing clients customized solutions in a dynamic investment environment. For more information, please visit www.tpg-ir.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the future success of our scientific studies, our ability to successfully develop products, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments, the financial resources available to us, and general economic conditions. Arrowhead Research Corporation's Annual Report on Form 10-K and 10-K/A, recent and forthcoming Quarterly Reports on Form 10-Q and 10-Q/A, recent Current Reports on Forms 8-K and 8-K/A, our Registration Statements on Form S-3, and other SEC filings discuss some of the important risk factors that may affect our business, results of operations and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.

For more information, please click here

Contacts:
Arrowhead Research Corporation
Virginia Dadey
212-541-3707

or
The Piacente Group
Sanjay M. Hurry
212-481-2050

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Consulting

First measurement of electron energy distributions, could enable sustainable energy technologies June 5th, 2020

Lucintel identifies and prioritizes opportunities for alumina trihydrate (ATH) fillers in the global composites industry August 3rd, 2016

Haydale Wins Major Research Grants September 26th, 2015

Silicon Valley-Based Foresight Valuation Launches STR-IP™, a New Initiative for Startups to Discover the Value of Their Intellectual Property December 18th, 2014

Investments/IPO's/Splits

Daikin Industries becomes OCSiAl shareholder July 27th, 2021

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021

180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project